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Introduction
Teamwork, creativity, adaptability, empathy—all
traits that physicians employ on a daily basis to
effectively deliver patient care. One may argue that
these are elements of physician-patient interaction
that artificial intelligence (AI) could never replicate.
However, others would contend that AI models have
already demonstrated some of these features. Recent
notable examples include AI mastering cooperative
gameplay and generative adversarial networks creating
novel artwork and melodic music.1–4 These advances
were all made possible due to the recent prolif-
eration of deep neural networks, which have also
ushered a stepwise improvement in machine learn-
ing performance in ophthalmology.5–8 However, it is
crucial to clarify that these and similar AI models
that show creativity, teamwork, and adaptability are
examples of “narrow” AI. These algorithms are
typically validated in constrained testing environments
and have limited generalizability. Furthermore, when
evaluated outside their test environments in a more
abstract fashion or presented with intentional adver-
sarial counterfactuals, they often fail with unfortunate
consequences.9
AI Challenges
Even considering the aforementioned examples,
which mimic certain elements of human behavior,
there has not yet been a demonstration of empathy
by an AI algorithm. In the context of medicine,
empathy comprises not only understanding a patient’s
feelings but, more important, also responding by deliv-
ering care in an appropriate manner. A health profes-
sional’s relationship with the patient helps guide the
patient’s care in the context of his or her unique
physical, emotional, and social environment. Further-
more, the doctor-patient relationship itself has been
shown to have a therapeutic effect in a system-
atic review of 25 randomized controlled trials.10
The patient-clinician interaction is innately human
and, in the words of patients themselves, depends
on “two humans who both can fully contextu-
alise and appreciate the patient’s values, wishes, and
preferences.”11
Beyond the human interaction component, translat-
ing AI from laboratory experiment to a real-world tool
entails additional challenges. “Do no harm,” the first
line of the Hippocratic Oath, signifies that physicians
employing tools such asAI in patient care deliverymust
maintain safety as the first priority. As Luke Oakden-
Rayner,12 a radiologist and critical AI blogger explains,
Silicon Valley’s ethos of “move fast break things” can
be especially dangerous in the context of medical AI.
When AI-assisted medical care transitions from triage
to diagnostic systems (Fig. 1), so too the inherent
risk increases. In ophthalmology, we currently lie at
the “dotted line,” as triage systems such as the ones
developed by IDX and Google DeepMind are precur-
sors of future diagnostic and predictive systems.5,13
The Moorfields DeepMind algorithm already has a
diagnostic component, and predictive systems are just
around the corner. Arcadu et al.14 describe a system
capable of predicting two-step worsening of diabetic
patients’ Early Treatment of Diabetic Retinopathy
Study (ETDRS) scores at 12monthswith an area under
the receiver operating characteristic curve (AUC) of
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Figure 1. Risks of medical AI. AI model risk increases as cognitive
complexity increases. We currently lie at the dotted line, a tipping
point between triage and diagnostic systems. Permission received
for reproduction from Luke Oakden Rayner.16
0.79, and a Google group recently described an
algorithm that could predict acute kidney injury 48
hours in advance.15
As these AI systems are poised to influence clini-
cal decision making, the risks become more appar-
ent, and prospective validation becomes more impor-
tant. As Oakden-Rayner12 suggests, validation studies
should focus on clinical outcomes of AI system imple-
mentation and not simply on prospective algorithm
performance validation. Ophthalmologists need to aim
for patient-specific outcomes such as vision loss and
disability while maintaining focus on health care–
specific outcomes such as reducing money spent
per intravitreal injection or surgery.16,17 Laboratory
performance does not equal outcomes, and this was
highlighted by the case of mass adoption of computer-
aided diagnosis (CAD) for mammography screening.
Although early reader studies showed that computers
working with radiologists led to better accuracy than
radiologists alone, subsequent clinical trials demon-
strated that false-positive rates increased after CAD
adoption. This led to an almost 20% increase in
the rate of biopsies, confirming the potential discon-
nect between diagnostic accuracy and clinical effective-
ness.16,17
Furthermore, as predictive algorithms become
implemented in clinical decision making, false positives
may become a self-fulfilling prophecy.18 An ophthal-
mologist will not know whether the patient predicted
to develop proliferative diabetic retinopathy, who was
subsequently treated with a prophylactic anti-Vascular
endothelial growth factor (VEGF) injection, will have
ever developed the disease if he or she was not treated.
When used in this manner, the algorithm’s false-
positive rates would be extremely difficult to detect—
even in large outcomes-based clinical trials. If that so-
called false-positive patient then went on to develop an
iatrogenic complication, unnecessary harm would be
inflicted and would be difficult to attribute to the AI’s
recommendation in any post hoc analyses.
Limitations of Deep Learning in
Ophthalmology
Even with the success of deep learning–based AI
models in the research setting, we must be cautious
by not inferring similar performance in real-world use.
Although deep learning has led to substantial advances
in image classification, it is not without shortcomings.
Gary Marcus19 has well summarized the limitations;
specific criticisms that are relevant to ophthalmology
include insufficient transparency, poor integration with
prior hierarchical knowledge, and inflexibility. Further-
more, a model’s evaluation metric may not be indica-
tive of the product’s or patient’s clinical goals.20 In an
illustrative clinical scenario, a deep learning AI model
that was optimized for reducingmacular thickness may
prove irrelevant, as evidence becomes available that
visual acuity may not correlate with this goal. This
inflexibility and inability to encode hierarchical prior
knowledge could quickly lead to a model’s gross under-
performance and rapid obsolescence.
AI models may break down when they encounter
dissimilar image acquisition and patient-specific
variables from those the model was trained on.
Although prospective observational clinical validation
is crucial to ensuring real-world model performance,
this kind of data is often lacking.21 It is frequently
difficult to determine the precise reason that these
models fail, and they are therefore often termed
“black boxes.”20,22,23 Furthermore, if these models
fail in screening settings, which often affect larger
numbers of people, unnecessary additional inter-
ventions have the potential for even higher impact.
This was exemplified by post hoc analyses of prior
large-scale computer-aided screening programs.17,24
Novel Uses of Ophthalmic AI
Nevertheless, advances in AI have not only shown
levels of performance that may supersede human
ophthalmologists but have also demonstrated profi-
ciency in tasks that were not previously thought possi-
ble for ophthalmologists to perform. Perhaps the most
striking is a recent demonstration that a deep learn-
ing algorithm could accurately predict cardiovascular
risk factors and demographics from fundus photos.4,25
This AI model predicted age with a mean absolute
error (MAE) of 3.26 years, sex with an AUC of 0.97,
smoking status with an AUCof 0.71, and systolic
blood pressure with aMAEof 11.23mmHg.Although
the ophthalmoscope was invented in the mid-1800s,
Ophthalmologists—More Human by Collaborating with AI TVST | Special Issue | Vol. 9 | No. 2 | Article 2 | 3
and ophthalmologists have been looking at the fundus
for as many years, these insights were not previously
conceivable.
Recent evidence continues to support the view
that the eye is a window to the vascular and central
nervous systems of the body. Associations between
retinal findings and neurodegenerative and cardiovas-
cular diseases such as Alzheimer disease and hyper-
tension have been increasingly validated.26–28 Future
advances in AI-based ophthalmic image analysis will
undoubtedly demonstrate unforeseen disease associa-
tions and their ophthalmic correlates. The ability of AI
systems to detect pixel-level patterns amongmillions of
pixels per image, comprised in data sets approaching
millions of patients, will never be matched by ophthal-
mologists. These occult patterns may enable not only
earlier systemic disease detection but also novel insights
into the pathophysiology of ophthalmic and systemic
diseases.
The Potential of an
Ophthalmologist-AI Partnership
Effective clinical medicine and ophthalmology with
its large data sets of longitudinal imaging will
ultimately benefit from collaborating with AI. Vergh-
ese et al.29 describe humans working with machines
and emphasize the lead time that predictive models can
offer for diagnosis and action. However, these models
can only lead to effective clinical decisions if they keep
human intelligence “in the loop” to bring context. As
with other imaging-heavy specialties such as radiol-
ogy, ophthalmology is positioned to lead the uptake
of medical AI. However, unlike radiologists, ophthal-
mologists additionally employ specialized examination
skills and perform complex microsurgery. Therefore,
ophthalmology is both uniquely positioned to take
advantage of AI yet also uniquely protected against
obsolescence to machines.
Concerns about physician unemployment have
historically been raised with any stepwise improve-
ments in automation and are often out of proportion
to reality. Verghese et al.29 reference an editorial from
1981 on using predictive risk factors from a then-novel
computer database, stating that “proper interpretation
and use of computerized data will depend as much on
wise doctors as any other source of data in the past.”30
While a recent US report states 47% of jobs are at risk
for automation, the risk for physicians and surgeons is
estimated to be 0.4%.31,32
As various automations inmedicine have freed clini-
cians from menial tasks, AI will continue that trend
by integrating the ever increasing volumes of clinical,
genomic, and imaging data. This will allow the ophthal-
mologist to focus on providing effective and compas-
sionate clinical care. Currently, the majority of time is
spent collating and synthesizing data and a minority
interacting with the patient. However, with such vast
volumes of data, the clinician would in effect be forced
to use an aid to perform the data processing and thus
have more time to be “deeply human”with the patient.
One can imagine a “clinic of the future”—a term
described by Eric Topol,33 in which a patient presents
with multimodal high-resolution images, functional
testing, genomic sequencing, metabolomic/proteomic
information, and sensor data from home monitor-
ing. Ophthalmologists would be provided a concise
summary comprising structural and functional trends.
They may also have access to richly annotated imaging
segmented and highlighted for trending changes.
Additional AI-synthesized predicted images could be
presented of disease course depending on various treat-
ment regimens. Consequently, ophthalmologists would
then use this information as an additional tool and,
together with the patient, formulate a treatment plan.
They would subsequently compare this plan with the
AI’s recommendations, as well as its predictions of
disease course and treatment response to select the best




Time is a precious commodity for both patients
and ophthalmologists. Patients often complain of
insufficient doctor contact; similarly, physicians are
increasingly burnt out from more time spent on cleri-
cal tasks than patient care.34 Although new technol-
ogy often promises efficiency improvements, as with
the case of the electronic health records, one can
see that such promises frequently fail to deliver. If
implemented correctly, AI is unique in its potential
to save time by processing large longitudinal data
volumes and efficiently representing the patterns identi-
fied. Ophthalmologists will have more time for physi-
cal patient contact—everting an eyelid to discover a
hidden conjunctival melanoma, performing a thorough
gonioscopy or cranial nerve examination, or perfecting
their surgical technique.
As described by Geoff Colvin,35 human brains were
designed for social interaction. No patient would want
to be informed that they have a terminal disease or
that they are going blind by their AI assistant. The
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new high-value skills will become those that “liter-
ally define us as humans,” sensing the thoughts and
feelings of patients losing vision, coordinating assistive
devices with family members, and allowing the patients
to express themselves about how their eyesight affects
their lives. Although many ophthalmologists disagree
with the concept of patient satisfaction influencing
reimbursement, this relatively new development is an
example of the increasing value being placed on such
human-metrics. Colvin35 states, “It used to be that you
had to be good at beingmachinelike. Now, increasingly,
you have to be good at being a person. Great perfor-
mance requires us to be intensely human beings.”
Conclusion
We currently lie in a stage between AI demonstra-
tion and deployment. Next comes ongoing evaluation,
learning, model adjustment, and finally meaningful
human-AI interaction. Ophthalmologists should lever-
age the primary strength of AI, its ability to glean
insights from large volumes of multivariate data, with
their abilities to interpret the AI’s recommendations
in a clinical and societal context. In doing so, the
field will be well positioned to lead the transforma-
tion of health care in a positive and personalized direc-
tion. As more time will become available for human-
suited tasks, ophthalmologists will have more time to
be human—we will just use a digital helping hand from
AI.
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